TriMed Research, Inc. To Present At BIO Mid-America VentureForum 2004

OMAHA, Neb.--(BUSINESS WIRE)--April 29, 2004--TriMed Research, Inc. announced today that Dr. David Winter, chief executive officer, will present at the BIO Mid-America VentureForum which will be held May 3-5, 2004 at the Chase Park Plaza Hotel in St. Louis. The BIO Mid-America VentureForum is the only nationally sponsored Midwest conference dedicated exclusively to biotechnology.

Dr. Winter will provide an overview of TriMed Research's plan to commercialize a naturally occurring mammary gland protein designated as MAA. MAA has been shown to actually prevent gastro-intestinal infections and could result in a new class of anti-infective compounds with therapeutic applications for both humans and animals. Potential applications include the prevention of life-threatening diseases in infants, reduction of farm animal disease, reduction of the debilitating side-effects of cancer treatments and even the prevention of "travelers' diarrhea."

Dr. Winter's presentation will begin at 3:00 p.m. on May 4. Additional information about the conference can be obtained at www.bio.org/midamerica.

About TriMed Research

TriMed Research, Inc. is focused on the commercialization of a naturally occurring mammary gland protein designated as MAA, and is now raising the funds necessary for animal research. The company is a joint venture of the University of Nebraska Medical Center, UNeMed Corporation and Tridelta Development, Ltd. For more information about TriMed Research, please visit www.trimedres.com.

Contacts

TriMed Research, Inc.

Danielle Cagan, 415/665-6678 danielle@cagancommunications.com